ConductScience.org, home

Paper39267682

Nrf2 in human cancers: biological significance and therapeutic potential.

Tian Y and 4 others. Am J Cancer Res, 2024. Cited by 9 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Nrf2 in human cancers: biological significance and therapeutic potential. Papers, record 39267682. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39267682

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nrf2 in human cancers: biological significance and therapeutic potential.
PubMed
Journal
Am J Cancer Res
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
1.53, provisional
iCite
Revised in PubMed
2024-09-14
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tian YYu
2Tang LLixin
3Wang XXin
4Ji YYanqin
5Tu YYanyang

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References246

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136829256Functions and mechanisms of lncRNA MALAT1 in cancer chemotherapy resistance.Biomark Res2023https://conductscience.org/library/papers/36829256PubMed
236823108Ibrutinib facilitates the sensitivity of colorectal cancer cells to ferroptosis through BTK/NRF2 pathway.Cell Death Dis2023https://conductscience.org/library/papers/36823108PubMed
336791159Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer.N Engl J Med2023https://conductscience.org/library/papers/36791159PubMed
411303500Pro-inflammatory programmed cell death.Trends Microbiol2001https://conductscience.org/library/papers/11303500PubMed
536909174Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2/GPX4 axis.Front Pharmacol2023https://conductscience.org/library/papers/36909174PubMed
630339884Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.Free Radic Biol Med2018https://conductscience.org/library/papers/30339884PubMed
736453238Triptolide promotes ferroptosis by suppressing Nrf2 to overcome leukemia cell resistance to doxorubicin.Mol Med Rep2023https://conductscience.org/library/papers/36453238PubMed
819967722Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin.J Pathol2010https://conductscience.org/library/papers/19967722PubMed
936948284Doxorubicin-loaded micelles in tumor cell-specific chemotherapy.Environ Res2023https://conductscience.org/library/papers/36948284PubMed
1035214073Ultrasound-Responsive Nrf2-Targeting siRNA-Loaded Nanobubbles for Enhancing the Treatment of Melanoma.Pharmaceutics2022https://conductscience.org/library/papers/35214073PubMed
1126341193Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.Drug Resist Updat2015https://conductscience.org/library/papers/26341193PubMed
1224011591Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy.Mol Cell2013https://conductscience.org/library/papers/24011591PubMed
1332319188β-Sitosterol-assisted silver nanoparticles activates Nrf2 and triggers mitochondrial apoptosis via oxidative stress in human hepatocellular cancer cell line.J Biomed Mater Res A2020https://conductscience.org/library/papers/32319188PubMed
1436933639Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpoint.Environ Res2023https://conductscience.org/library/papers/36933639PubMed
1536715963Adipokines and epithelial-mesenchymal transition (EMT) in cancer.Mol Cell Biochem2023https://conductscience.org/library/papers/36715963PubMed
1633393215MOAP-1-mediated dissociation of p62/SQSTM1 bodies releases Keap1 and suppresses Nrf2 signaling.EMBO Rep2021https://conductscience.org/library/papers/33393215PubMed
1732274363Overexpression of Nrf2 promotes colon cancer progression via ERK and AKT signaling pathways.Ann Surg Treat Res2020https://conductscience.org/library/papers/32274363PubMed
1835011574miR-140-5p Attenuates Hypoxia-Induced Breast Cancer Progression by Targeting Nrf2/HO-1 Axis in a Keap1-Independent Mechanism.Cells2021https://conductscience.org/library/papers/35011574PubMed
1933416106ROS‑mediated hypomethylation of PRDX5 promotes STAT3 binding and activates the Nrf2 signaling pathway in NSCLC.Int J Mol Med2021https://conductscience.org/library/papers/33416106PubMed
2026122708Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease.Free Radic Biol Med2015https://conductscience.org/library/papers/26122708PubMed

See all 246 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42797750Neodymium Nitrate Suppresses Malignant Phenotypes in Hep-G2 Cells by Targeting Nrf2 to Inhibit EMT and Induce Ferroptosis.Toxics2026https://conductscience.org/library/papers/42797750PubMed
41656817[Role and mechanisms of FoxO3a-related signaling pathways in breast cancer cell apoptosis].Zhong Nan Da Xue Xue Bao Yi Xue Ban2025https://conductscience.org/library/papers/41656817PubMed
41470226Effects of the Pharmacological Modulation of NRF2 in Cancer Progression.Medicina (Kaunas)2025https://conductscience.org/library/papers/41470226PubMed
41301693The Role of Mitochondrial Genome Stability and Metabolic Plasticity in Thyroid Cancer.Biomedicines2025https://conductscience.org/library/papers/41301693PubMed
40940829Targeting Cancer Translational Plasticity: IRES-Driven Metabolism and Survival Within the Tumor Microenvironment.Cancers (Basel)2025https://conductscience.org/library/papers/40940829PubMed
40732256Bardoxolone Methyl: A Comprehensive Review of Its Role as a Nrf2 Activator in Anticancer Therapeutic Applications.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40732256PubMed
40649894Repurposing Dimethyl Fumarate Targeting Nrf2 to Slow Down the Growth of Areas of Geographic Atrophy.Int J Mol Sci2025https://conductscience.org/library/papers/40649894PubMed
39940878Ligustrazine hydrochloride Prevents Ferroptosis by Activating the NRF2 Signaling Pathway in a High-Altitude Cerebral Edema Rat Model.Int J Mol Sci2025https://conductscience.org/library/papers/39940878PubMed
39872524Top 100 most-cited articles on apoptosis of non-small cell lung cancer over the past two decades: a bibliometrics analysis.Front Immunol2024https://conductscience.org/library/papers/39872524PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
NFE2L24780PubTator's text mininghttps://conductscience.org/library/genes/4780

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39267682

GET https://conductscience.org/api/papers/v1/39267682/references?page=2